McKesson Corp. (NYSE:MCK), San Francisco, CA, reported that sales for the second quarter ended Sept. 30, 2013, were $33 billion, up 11 percent from a year ago. Profit for the second quarter was $404 million.
Distribution Solutions revenues were up 11 percent in the second quarter, driven mainly by strong growth in U.S. pharmaceutical direct distribution and services revenues due to market growth, mix of business and one additional sales day. In the second quarter, Distribution Solutions operating profit was $685 million.
Canadian revenues, on a constant currency basis, increased 14 percent for the second quarter primarily due to market growth and new customer wins. Including an unfavorable currency impact of 5 percent, Canadian revenues increased 9 percent for the second quarter.
Medical-Surgical distribution and services revenues were up 68 percent for the second quarter driven primarily by the acquisition of PSS World Medical and market growth.
Technology Solutions revenues were up 8 percent in the second quarter compared to the prior year driven primarily by acquisitions completed in the prior year. Operating profit was $113 million for the second quarter.
For the first half of the year, sales were $65.1 billion, up 8 percent from the prior-year period. Profit was $828 million.
In the first half of the year, McKesson spent $116 million on acquisitions.
